For the first time, Canadians will have access to at-home HIV self test kits.
Vancouver’s bioLytical Laboratories announced today that it has received Health Canada Licence to produce and sell its highly accurate, 1-minute INSTI® HIV Self Tests in Canada.
Likened to a home pregnancy test, the INSTI®HIV Self Test allows individuals to screen and monitor for HIV in the comfort of their own home, using easy-to-understand, three-step instructions. Testers collect one drop of blood using a simple fingerstick method and receive results that are more than 99 per cent accurate in only 1 minute.
The INSTI® HIV Self Test is part of bioLytical’s world-leading line of 1-minute tests for infectious diseases including HIV, Hepatitis C, Syphilis and now, COVID-19.
“Ending the HIV epidemic starts with testing. By providing innovative options like our 1-minute INSTI® HIV Self Test, we can help people who are unaware of their HIV status to learn the facts and make informed health decisions much faster,” says bioLytical’s Chief Executive Officer, Robert Mackie.
“In addition, bioLytical has received approval in Europe and is currently in FDA trials for our COVID-19 Antibody test, which uses the same 1-minute INSTI® self-testing technology.”
The test will be available for purchase this week from INSTI.com.